Axim Biotechnologies, Inc.

Axim Biotechnologies, Inc. increased I. Quarter net loss per share of $-0.05 compare to net loss per share of $-0.01 recorded in the same quarter a year ago a decrease compare to $-0.03 realized in previous quarter.

Axim Biotechnologies's Revenue fell by % in I. Quarter (Mar 31 2018) year on year, to $0 million and declined by -7.82 % sequentially.
More on AXIM's Income Statement

I. Quarter Earnings Per Share Revenues $ -0.05 $  0 Mill $-0.04     Unch.     -23.48 %

You need to upgrade your Flash Player

AXIM's NET INCOME

Axim Biotechnologies's in I. Quarter recorded net loss of $-3 million, an increase from net loss of $-1 million in I. Quarter a year ago.

Sequentially net loss advanced

More on AXIM's Growth

Inventories Inventories declined by -16.54 % to $0.01 million from I. Quarter a year ago, sequentially inventories fell by -11.26 %. In I. Quarter company's net cash and cash equivalents decreased by $-1 million